1. Yan, X., Yeh, C., & Zou, L. Clinical Applications of Circulating Tumor DNA, Circulating Tumor Cells, & Exosomes as Liquid Biopsy-Based Tumor Biomarkers[J]. Journal of Applied Bioanalysis, Volume 6, No. 3, August 2020.
2. Zhang, X., Zhang, Z., Shao, W., Lin Z., & Zou, L. A Review on LBA & LC-MS Platforms for Supporting Large Molecule Pharmacokinetics Bioanalysis[J]. Journal of Bioanalysis & Biomedicine, DOI: 10.37421/jbabms.2020.12.227, Volume 12:3, 2020.
3. Zhong, Z.D., Jiang, L., Khandelwal, P., Clarke, A.W., Bakhtiar, R., Zou, L. Development & Utility of an ELISA Method for Sensitive & Specific Detection of IgE Antidrug Antibodies[J]. The AAPS Journal. volume 22, Article number: 36, 2020.
4. Zou, L. & Nock S. Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study[J]. Book title: Polymer-Protein Conjugates. Elsevier, ISBN: 9780444640819, 2019.
5. Federman, N, Dragomir, MD, Kizyma, Z, Roganovic, J, Bias, P, Lammerich, A, Ben Arie, ZR, Zou, L, Hoehn G, Buchner A. A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Myelosuppressive Chemotherapy[J]. Journal of Pediatric Hematology/Oncology. 41: 525-531, 2019.
6. Zou, L., Buchner, A., Field, F., Barash, S. & Liu, P.M. Immunogenicity Assessment of Tbo-Filgrastim in Cancer Patients Receiving Chemotherapy[J]. Bioanalysis 10: 1221-1228, 2018.
7. Gupta, S., Richards, S., Amaravadi, L., Piccoli, S.,Desilva, B., Pillutla, R., Stevenson, L., Mehta, D., Carrasco-Triguero, M., Neely, R., Partridge,M., Staack, R.F., Zhao, X., Gorovits, B., Kolaitis, G., Sumner, G., Stubenrauch, K., Zou, L., et al. 2017 White Paper on Recent Issues in Bioanalysis: A Global Perspective on Immunogenicity Guidelines & Biomarker Assays Performance (Part 3 – LBA: Immunogenicity, Biomarkers & PK Assays) [J]. Bioanalysis 9: 1967-1996, 2017.
8. Marc-Olivier, M., Zou, L., Faust, H., Abdolzade-Bavil, A., Liu, P.M. Petra Struwe, P. Method establishment for discerned immunogenicity assessment of a recombinant glycoprotein containing nonhuman sialic acid Neu5Gc residues[J]. Bioanalysis 9: 1385–1393, 2017.
9. Zou, L., Buchner, A., Roberge M., & Liu, P.M. Immunogenicity assessment of lipegfilgrastim in patients with breast cancer receiving chemotherapy[J]. Journal of Immunology Research 23; 2016: 9248061. Epub 2016 Dec 23.
10. Liu, P.M., Zou, L., Sadhu, C., Shen W.D., & Nock, S. Comparative immunogenicity assessment: a critical consideration for biosimilar development (Invited Review) [J]. Bioanalysis 7: 373–381, 2015.
11. Liu, P.M., Handl, H., Zou, L., & Kim, B. Immunobiological aspects of therapeutic antibodies & related characterization approaches (Invited review) [J]. Current Opinion in Drug Discovery & Development 10: 515-522, 2007.
12. Chen, Q., Long, Y., Yuan, X., Zou, L., Sun J., Chen S., Perez-Polo J.R., Yang K. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors[J]. Journal of Neuroscience Research 80: 611-619, 2005.
13. Long, Y., Zou, L., Liu, H., Lu, H., Yuan, X.Q., Robertson, C.S., & Yang, K. Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury[J]. Journal of Neuroscience Research 71: 710-720, 2003.
14. Zou, L., Yuan, X.Q., Long, Y., Shine, H.D., & Yang, K. Improvement of cognitive function after adenovirus-mediated transfer of nerve growth factor gene to aged rat brain[J]. Human Gene Therapy 13: 2173-2184, 2002.
15. Zou, L., Yotnda, P., Zhao, T., Yuan, X., Long, Y., Zhou, H., & Yang, K. Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain[J]. Journal of Cerebral Blood Flow & Metabolism 22: 959-970, 2002.
16. Kumar, A., Zou, L., Yuan, X.Q., Long, Y., & Yang, K. NMDA receptors: transient loss of NR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model[J]. Journal of Neuroscience Research 67: 781-786, 2002.
17. Zou, L., Yuan, X., Zhou, H., Lu, H., & Yang, K. Helper-dependent adenoviral vector (hdAdv)-mediated gene transfer in aged rat brain[J]. Human Gene Therapy 12: 181-191, 2001.
18. Zou, L., Zhou, H., Pastore, L., & Yang, K. Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAdv) in the central nervous system[J]. Molecular Therapy 2: 105-113, 2000.
19. Xu F.J., Xia W.Y., Luo R.Z., Peng H.Q., Zhao S.L., Dai J.Y., Long Y., Zou, L., Le W.D., Liu J.S., Parlow A.F., Hung MC., Bast RC, Jr., & Yu YH. The human ARHI tumor suppressor gene inhibits lactation & growth in transgenic mice[J]. Cancer Research 60: 4913-4920, 2000.
20. Mohamed, H.A., Mosier, D., Zou, L., Siklos, L., Alexianu, M., Engelhardt, J., Beers, D.R., Le, W., & Appel, S.H. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, & neurotransmitter release in motor neurons[J]. Journal of Neuroscience Research 69: 110-116, 2002.
21. Zou, L., Xu, J., Jankovic, J., He, Y., Appel S.H., & Le, W. D. Pramipexole inhibits lipid peroxidation & reduces MPTP-induced nigral injury in C57BL/6 mice[J]. Neuroscience Letter 281: 167-170, 2000.
22. Zou, L., Huang, L., Hayes, R.L., Black, C., Qiu, Y.H., Perez-Polo, J.R., Le, W., Clifton, G.L., & Yang, K. Liposome-mediated NGF gene transfection following neuronal injury: Potential therapeutic applications[J]. Gene Therapy 6: 994-1005, 1999.
23. Zou, L., Jankovic, J., Rowe, D.B., Xie, W.J., Appel, S.H., & Le, W.D. Neuroprotection by pramipexole against dopamine- & levodopa-induced neurotoxicity[J]. Life Science 64: 1275-1285, 1999.
24. Le W.D., Conneely OM, Zou, L., He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, & Appel SH. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice[J]. Experimental Neurology 159: 451-458, 1999.
25. Zou, L., Lu, H., Coleman, M., Abruzzese, R., Nordstrom, J., Wang, J., Ozol, K., Hayes, R., & Yang, K. Liposome mediated RU486-regulated gene transfer in CNS cell & tissue: potential in gene therapy for traumatic brain injury[J]. Journal of Neurotrauma 16: 1006, 1999.
26. Guo, X., Zou, L., & Jin, G.Z. D1/D2 interaction in membrane abolished by 6-OHDA lesion[J]. Life Science 63: PL7-PL13, 1998.
27. Guo, X., Liu, J., Zou, L., Jin, J, Wang, B.C., & Jin, G.Z. Enhancement of (-) -stepholidine on protein phosphorylation of a dopamine- & cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats[J]. Acta Pharmacology Sinica 19: 100-104, 1998.
28. Zou, L., Liu, J., & Jin, G.Z. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats[J]. Biochemical Pharmacology 54: 233-240, 1997.
29. Zou, L., Chen, Y., Song, Y., & Jin, G.Z. Effect of (-)-stepholidine on serum prolactin level of female rats[J]. Acta Pharmacology Sinica 17: 311-314, 1996.
30. Zou, L., Cai, S., & Jin, G.Z. Chronic treatment with (-)-stepholidine alters the density & turnover of striatal D1 & D2 receptors[J]. Acta Pharmacology Sinica 17: 485-489, 1996.
